Bellevue Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.11M Buy
+6,196
New +$1.01M 0.02% 101
2026
Q1
– Sell
-3,004
Closed -$307K – 172
2025
Q4
$307K Buy
3,004
+1,051
+54% +$94K 0.01% 147
2025
Q3
$122K Buy
+1,953
New +$106K ﹤0.01% 137
2023
Q4
– Sell
-74,525
Closed -$2.21M – 168
2023
Q3
$2.21M Sell
74,525
-7,672
-9% -$270K 0.04% 112
2023
Q2
$2.94M Hold
82,197
– – 0.04% 108
2023
Q1
$1.93M Sell
82,197
-53,258
-39% -$1.52M 0.03% 116
2022
Q4
$3.68M Buy
135,455
+73,372
+118% +$3.36M 0.05% 116
2022
Q3
$3.34M Sell
62,083
-8,497
-12% -$436K 0.05% 114
2022
Q2
$2.85M Sell
70,580
-139,132
-66% -$6.89M 0.04% 120
2022
Q1
$13.9M Sell
209,712
-83,900
-29% -$5.74M 0.16% 102
2021
Q4
$29.4M Sell
293,612
-46,282
-14% -$4.79M 0.3% 88
2021
Q3
$42.5M Sell
339,894
-39,715
-10% -$4.72M 0.43% 73
2021
Q2
$47.1M Buy
379,609
+76,743
+25% +$10.3M 0.46% 69
2021
Q1
$46.2M Buy
302,866
+123,625
+69% +$18.7M 0.49% 65
2020
Q4
$23.1M Buy
179,241
+16,858
+10% +$1.94M 0.26% 95
2020
Q3
$18.2M Buy
162,383
+35,822
+28% +$3.28M 0.25% 93
2020
Q2
$10.3M Buy
126,561
+21,267
+20% +$1.71M 0.15% 107
2020
Q1
$7.33M Sell
105,294
-4,842
-4% -$372K 0.14% 101
2019
Q4
$8.61M Buy
110,136
+15,375
+16% +$1.11M 0.14% 100
2019
Q3
$6.05M Sell
94,761
-25,087
-21% -$2.21M 0.11% 103
2019
Q2
$10.3M Buy
119,848
+10,196
+9% +$779K 0.18% 84
2019
Q1
$8.41M Buy
109,652
+535
+0.5% +$29.7K 0.46% 61
2018
Q4
$4.1M Buy
+109,117
New +$4.02M 0.27% 74

Other funds holding GH

Bellevue Group's GH Position: Q3 2026 in Review

Bellevue Group opened a new position in Guardant Health (GH) in Q3 2026: 6,196 shares worth $1.11M. The stake represents 0.02% of the portfolio and ranks #101 among its holdings. This is a return to the name: Bellevue Group previously reported a position in GH as recently as Q4 2025.

Bellevue Group first reported a position in GH in Q4 2018 and has held it in 23 quarters since. The position peaked at $47.1M in Q2 2021. 673 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Bellevue Group held 6,196 shares of Guardant Health worth $1.11M as of Q3 2026.
  • Guardant Health was a new Bellevue Group position in Q3 2026.
  • Guardant Health made up 0.02% of Bellevue Group's portfolio in Q3 2026, its #101 holding.
  • Bellevue Group first reported a position in Guardant Health in Q4 2018 and has held it in 23 quarters since.
  • Bellevue Group's Guardant Health position peaked at $47.1M in Q2 2021.
  • 673 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Bellevue Group's 13F filing for Q3 2026, filed 16 Nov 2026.